FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Meropenem I Recall

Meropenem I

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Dec 24, 2014
Recall ID
D-0303-2015
Check your lot numberHow we source this data

Summary

Hospira recalled Meropenem I starting Oct 24, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0303-2015 on Dec 24, 2014. Reason: Defective Container: Glass vials may crack due to low (thin) out of specification vial wall thickness which may lead to contamination and lack of assurance of sterility. Status: Terminated.

Why it was recalled

Defective Container: Glass vials may crack due to low (thin) out of specification vial wall thickness which may lead to contamination and lack of assurance of sterility.

Product description

Meropenem I.V. 1 g is supplied in 30 mL injection vials, RX only. Manufactured by Hospira Healthcare India Pvt. Ltd Tamil Nadu, India for Hospira, Inc. 275 N. Field Drive, Lake Forest, IL 60045. NDC 0409-3506-01

Lot numbers, UPCs & expiration codes

Lot #: 609E014, Exp 1/2016; 609E015, Exp 1J/2016; 609E016, Exp 1/2016; 609E017, Exp 1/2016; 609E018, Exp 1/2016; 609E019, Exp 1/2016; 601E025, Exp 1/2016; 601E027, Exp 1/2016; 601E028A, Exp 1/2016; 601E028B, Exp 1/2016; 601E028C, Exp 1/2016

Where it was sold

Nationwide and Puerto Rico, Italy, Netherland, Spain

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0303-2015
Classification
Class II
Status
Terminated
Recall initiated
Oct 24, 2014
FDA report date
Dec 24, 2014
Quantity
261,706 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-0303-2015, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
69798
Address
275 N Field Dr
Code information
Lot #: 609E014, Exp 1/2016; 609E015, Exp 1J/2016; 609E016, Exp 1/2016; 609E017, Exp 1/2016; 609E018, Exp 1/2016; 609E019, Exp 1/2016; 601E025, Exp 1/2016; 601E027, Exp 1/2016; 601E028A, Exp 1/2016; 601E028B, Exp 1/2016; 601E028C, Exp 1/2016
Postal code
60045-2579
Report date
Dec 24, 2014
Product type
Drugs
Recall number
D-0303-2015
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
261,706 vials
Termination date
Dec 15, 2016
Reason for recall
Defective Container: Glass vials may crack due to low (thin) out of specification vial wall thickness which may lead to contamination and lack of assurance of sterility.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Meropenem I.V. 1 g is supplied in 30 mL injection vials, RX only. Manufactured by Hospira Healthcare India Pvt. Ltd Tamil Nadu, India for Hospira, Inc. 275 N. Field Drive, Lake Forest, IL 60045. NDC 0409-3506-01
Distribution pattern
Nationwide and Puerto Rico, Italy, Netherland, Spain
Recall initiation date
Oct 24, 2014
Initial firm notification
Letter
Center classification date
Dec 18, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0303-2015, published Dec 24, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls